Orient Pharma Co., Ltd. (TPEX:4166)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan Business Division	1.07B	826.45M	-	-	-
Taiwan Business Division Growth	29.61%	-	-	-	-
Overseas Business Division	329.26M	396.37M	39.02M	63.07M	45.91M
Overseas Business Division Growth	-16.93%	915.94%	-38.14%	37.37%	339.39%
Plant Operating Department	-	-	847.11M	446.27M	416.30M
Plant Operating Department Growth	-	-	89.82%	7.20%	3.97%
Pharmaceutical Operations	-	-	3.78M	2.52M	1.13M
Pharmaceutical Operations Growth	-	-	50.24%	122.83%	-0.88%
Total	1.40B	1.22B	889.91M	511.86M	463.34M
Total Growth	14.52%	37.41%	73.86%	10.47%	12.46%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	1.07B	826.45M	679.80M	253.78M	323.43M
Taiwan Growth	29.61%	21.57%	167.88%	-21.54%	-21.50%
United States	232.29M	325.83M	178.49M	216.26M	108.62M
United States Growth	-28.71%	82.55%	-17.46%	99.09%	-
Philippines	48.68M	13.25M	23.81M	-	-
Philippines Growth	267.36%	-44.34%	-	-	-
China	193.00K	34.43M	18.00K	37.92M	17.14M
China Growth	-99.44%	191155.56%	-99.95%	121.16%	-
Others	48.09M	22.86M	7.80M	3.91M	14.15M
Others Growth	110.38%	193.23%	99.23%	-72.34%	-
Total	1.40B	1.22B	889.91M	511.86M	463.34M
Total Growth	14.52%	37.41%	73.86%	10.47%	12.46%

Source: S&P Global Market Intelligence.